Leading Pharmaceutical Innovation: Trends and Drivers for Growth in the Pharmaceutical Industry
Autor Oliver Gassmann, Gerrit Reepmeyer, Maximilian von Zedtwitzen Limba Engleză Hardback – 3 mar 2008
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 388.66 lei 38-44 zile | |
| Springer – 6 noi 2010 | 388.66 lei 38-44 zile | |
| Hardback (1) | 376.72 lei 6-8 săpt. | |
| Springer Berlin, Heidelberg – 3 mar 2008 | 376.72 lei 6-8 săpt. |
Preț: 376.72 lei
Nou
Puncte Express: 565
Preț estimativ în valută:
72.09€ • 75.60$ • 60.11£
72.09€ • 75.60$ • 60.11£
Carte tipărită la comandă
Livrare economică 08-22 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783540776352
ISBN-10: 3540776354
Pagini: 204
Ilustrații: XVI, 186 p. 47 illus.
Dimensiuni: 155 x 235 x 17 mm
Greutate: 0.41 kg
Ediția:2nd ed. 2008
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3540776354
Pagini: 204
Ilustrații: XVI, 186 p. 47 illus.
Dimensiuni: 155 x 235 x 17 mm
Greutate: 0.41 kg
Ediția:2nd ed. 2008
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
V-ar putea interesa
-
Competing Against Luck: The Story of Innovation and Customer ChoiceClayton M. ChristensenPreț: 120.76 lei -
-18%Preț: 197.97 lei241.43 lei -
Product Platform and Product Family Design: Methods and ApplicationsTimothy W. Simpson-18%Preț: 1623.02 lei1979.29 lei -
Preț: 126.33 lei -
Preț: 244.69 lei -
More Than a Showroom: Strategies for Winning Back Online ShoppersDaniel G. BachrachPreț: 203.78 lei -
Preț: 96.41 lei -
-12%Preț: 315.84 lei359.27 lei -
Product LeadershipRichard BanfieldPreț: 213.06 lei -
Make No Mistake!: An Outcome-Based Approach to Mistake-ProofingC. Martin Hinckley-25%Preț: 502.62 lei670.62 lei -
Scrum in easy stepsDavid MorrisPreț: 76.98 lei -
-15%Preț: 625.40 lei735.77 lei -
-14%Preț: 565.03 lei657.01 lei
Public țintă
Professional/practitionerCuprins
Innovation: Key to Success in the Pharmaceutical Industry.- The Industry Challenge: Do You Really Want to Be in This Business?.- The Science and Technology Challenge: How to Find New Drugs.- The Pipeline Management Challenge: How to Organize Innovation.- The Internationalization Challenge: Where to Get Access to Innovation.- Management Answers to Pharmaceutical R&D Challenges.- Future Directions and Trends.
Recenzii
From the reviews:
"This book examines the international pharmaceutical industry with special emphasis on the current and emerging research methodologies … . What distinguishes this book from others on the same subject is its emphasis on empirical findings (53 figures, 20 tables) and an exceptionally good, if short, discussion of various research technologies … . The six-page glossary of industry terms, when used with its decent index, is a particular joy. … recommend this offering to prospective managers and researchers in this industry … ." (Robert R. Rothberg, Journal of Product Innovation Management, Vol. 22, 2005)
From the reviews of the second edition:
“Leading Pharmaceutical Innovation, Gassmann and colleagues describe the current status of the pharmaceutical industry … . This book comprises seven chapters, where each could be seen as a review of the addressed topic. This helps with understanding the complexity of the challenges the pharmaceutical industry is facing, in comparison to the automotive industry or with respect to marketing problems … . book provides most valuable insight into the pharmaceutical industry from an ‘outsiders’ perspective.” (Sandrine Shepard and Thomas Wilckens, R&D Management, Vol. 40 (5), November, 2010)
"This book examines the international pharmaceutical industry with special emphasis on the current and emerging research methodologies … . What distinguishes this book from others on the same subject is its emphasis on empirical findings (53 figures, 20 tables) and an exceptionally good, if short, discussion of various research technologies … . The six-page glossary of industry terms, when used with its decent index, is a particular joy. … recommend this offering to prospective managers and researchers in this industry … ." (Robert R. Rothberg, Journal of Product Innovation Management, Vol. 22, 2005)
From the reviews of the second edition:
“Leading Pharmaceutical Innovation, Gassmann and colleagues describe the current status of the pharmaceutical industry … . This book comprises seven chapters, where each could be seen as a review of the addressed topic. This helps with understanding the complexity of the challenges the pharmaceutical industry is facing, in comparison to the automotive industry or with respect to marketing problems … . book provides most valuable insight into the pharmaceutical industry from an ‘outsiders’ perspective.” (Sandrine Shepard and Thomas Wilckens, R&D Management, Vol. 40 (5), November, 2010)
Textul de pe ultima copertă
Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. Our findings are illustrated by cases from Europe, the US, and Asia.
"One way we try to foster innovation - both the technological innovation and the organizational innovation - is to align our business objectives with our ideals."
Dr. Daniel Vasella, CEO, Novartis International
"Pharmaceutical innovation is in crisis. The industry will have to change both its innovation processes and its business models in order to reverse these trends and prosper in the future. Professors Gassmann, Reepmeyer and von Zedtwitz have marshalled together an impressive array of research in one volume. This book should prove to be an indispensable resource for all participants in the pharmaceutical industry."
Prof. Henry Chesbrough, Executive Director, Center for Open Innovation, Haas School of Business, University of California, Berkeley
"It´s time for a paradigm shift in pharmaceutical R&D. This book will tell you why."
Dr. Goetz Baumann, Business Unit Manager, Hoffmann-La Roche (Germany)
"This book offers a fact based, comprehensive insight to the increasing challenges of today`s drug development. Well worth reading not just for newcomers to the industry but also for industry professionals who want to understand the big picture".
Dr. Pius Renner, Head of Strategic Planning and Portfolio Management in Development, Novartis Pharma
"One way we try to foster innovation - both the technological innovation and the organizational innovation - is to align our business objectives with our ideals."
Dr. Daniel Vasella, CEO, Novartis International
"Pharmaceutical innovation is in crisis. The industry will have to change both its innovation processes and its business models in order to reverse these trends and prosper in the future. Professors Gassmann, Reepmeyer and von Zedtwitz have marshalled together an impressive array of research in one volume. This book should prove to be an indispensable resource for all participants in the pharmaceutical industry."
Prof. Henry Chesbrough, Executive Director, Center for Open Innovation, Haas School of Business, University of California, Berkeley
"It´s time for a paradigm shift in pharmaceutical R&D. This book will tell you why."
Dr. Goetz Baumann, Business Unit Manager, Hoffmann-La Roche (Germany)
"This book offers a fact based, comprehensive insight to the increasing challenges of today`s drug development. Well worth reading not just for newcomers to the industry but also for industry professionals who want to understand the big picture".
Dr. Pius Renner, Head of Strategic Planning and Portfolio Management in Development, Novartis Pharma
Caracteristici
The book is based on the three most important challenges in pharmaceutical innovation: productivity dilemma, new technology trends, globalization and outsourcing Due to the CTO-roundtable with 14 selected international experts in pharmaceutical R&D whose result is presented, the book has a strong perspective from senior management With management concepts and tools enabling leaders in the pharmaceutical industry to cope with new challenges and trends Includes supplementary material: sn.pub/extras
Descriere
Descriere de la o altă ediție sau format:
Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. Our findings are illustrated by cases from Europe, the US, and Asia.
Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. Our findings are illustrated by cases from Europe, the US, and Asia.